Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized open-label crossover self-controlled multicenter phase 3 study of urea [14C] capsules for diagnosis of Helicobacter pylori infection
CTR20261330Phase 3Completed
- Sponsor
- Shenzhen Furuikang Technology
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of urea in Helicobacter pylori infection, sponsored by Shenzhen Furuikang Technology. Started May 2026; status: completed.
02
Drugs
urea
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on CTR20261330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261330.